Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides

Journal of Colloid and Interface Science

Volumn 475, Issue , 2016, Pages 161-170

  Braun, Katharina ^a   Pochert, Alexander ^a   Lindén, Mika ^a   Davoudi, Mina ^b   Schmidtchen, Artur ^b,c   Nordström, Randi ^d   Malmsten, Martin ^d  

^a UNIVERSITY OF ULM   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antimicrobial peptide; Drug delivery; Membrane; Mesoporous silica

Indexed keywords

DRUG DELIVERY; DRUG INTERACTIONS; DYES; MEMBRANES; MICROORGANISMS; NANOPARTICLES; PEPTIDES; POLYPEPTIDES; SILICA;

ANTI-MICROBIAL EFFECTS; ANTIMICROBIAL PEPTIDE; MESOPOROUS NANOPARTICLE; MESOPOROUS SILICA; MESOPOROUS SILICA NANOPARTICLES; MESOPOROUS SILICA PARTICLES; NANOPARTICLE PROPERTIES; NEGATIVE SURFACE CHARGES;

MESOPOROUS MATERIALS;

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; HEMOGLOBIN; MESOPOROUS SILICA NANOPARTICLE; NANOCARRIER; TRITON X 100; ANTIINFECTIVE AGENT; DRUG CARRIER; NANOPARTICLE; SILICON DIOXIDE;

ADSORPTION; ARTICLE; CONTROLLED STUDY; DESORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELLIPSOMETRY; ERYTHROCYTE; ESCHERICHIA COLI; HEMOLYSIS; HUMAN; HUMAN CELL; LIPID BILAYER; LIPID MEMBRANE; MEMBRANE BINDING; MEMBRANE DAMAGE; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SURFACE CHARGE; SURFACE PROPERTY; ZETA POTENTIAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST;

ADSORPTION; ANTI-BACTERIAL AGENTS; CELL SURVIVAL; DRUG CARRIERS; ERYTHROCYTES; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; PARTICLE SIZE; POROSITY; SILICON DIOXIDE; SURFACE PROPERTIES;

EID: 84965158302     PISSN: 00219797     EISSN: 10957103     Source Type: Journal    
DOI: 10.1016/j.jcis.2016.05.002     Document Type: Article

References (36)

1. Chambers H.F., Deleo F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 2009, 7:629-641.
2. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 2005, 3:238-250.
3. Hancock R.E., Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24:1551-1557.
4. Strömstedt A.A., Ringstad L., Schmidtchen A., Malmsten M. Interaction between amphiphilic peptides and phospholipid membranes. Curr. Opin. Colloid Interf. Sci. 2010, 15:467-478.
5. Schmidtchen A., Malmsten M. Peptide interactions with bacterial lipopolysaccharides. Curr. Opin. Colloid Interf. Sci. 2013, 18:381-392.
6. Gaspar D., Veiga A.S., Castanho M.A.R.B. From antimicrobial to anticancer peptides. A review. Front. Microbiol. 2013, 4:1-16.
7. Schmidtchen A., Pasupuleti M., Mörgelin M., Davoudi M., Alenfall J., Chalupka A., Malmsten M. Boosting antimicrobial peptides by hydrophobic oligopeptide end-tags. J. Biol. Chem. 2009, 284:17584-17594.
8. Strömstedt A.A., Pasupuleti M., Schmidtchen A., Malmsten M. Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, and internal segment of LL-37. Antimicrob. Agents Chemother. 2009, 53:593-602.
9. Singh S., Papareddy P., Mörgelin M., Schmidtchen A., Malmsten M. Effects of PEGylation on membrane and lipopolysaccharide interactions of host defense peptides. Biomacromolecules 2014, 15:1337-1345.
10. Veronese F.M., Mero A. The impact of PEGylation on biological therapies. Biodrugs 2008, 22:315-329.
11. van der Ven B.C., Fahey R.J., Lee W., Liu Y., Abramovitch R.B., Memmott C., Crowe A.M., Eltis L.D., Perola E., Deininger D.D., Wang T., Locher C.P., Russell D.G. Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment. PLoS Pathog. 2015, 11(e1004679):1-20.
12. Malmsten M. Soft drug delivery systems. Soft Matter 2006, 2:760-769.
13. Malmsten M. Inorganic nanomaterials as delivery systems for proteins, peptides, DNA, and siRNA. Curr. Opin. Colloid Interf. Sci. 2013, 18:468-480.
14. Vivero-Escoto J.L., Slowing I.I., Trewyn B.G., Lin V.S.-Y. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 2010, 6:1952-1967.
15. Gultepe E., Nagesha D., Sridhar S., Amiji M. Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices. Adv. Drug Deliv. Rev. 2010, 62:305-315.
16. Fadeel B., Garcia-Bennett A.-E. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug Deliv. Rev. 2010, 62:362-374.
17. Durr H.H.N., Sudheendra U.S., Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta 2006, 9:1408-1425.
18. Rosenholm J.M., Meinander S., Peuhu E., Niemi R., Eriksson J.E., Sahlgren C., Lindén M. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 2009, 3:197-206.
19. 2 spheres. J. Mater. Sci. Eng. A 2013, 3:237-242.
20. He Q., Shi J., Zhu M., Chen Y., Chen F. The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid. Micropor. Mesopor. Mater. 2010, 131:314-320.
21. Puddu V., Perry C.C. Peptide adsorption on silica nanoparticles: evidence of hydrophobic interactions. ACS Nano 2012, 6:6356-6363.
22. Schmidtchen A., Ringstad L., Kasetty G., Mizuno H., Rutland M.W., Malmsten M. Membrane selectivity by W-tagging of antimicrobial peptides. Biochim. Biophys. Acta 2011, 1808:1081-1091.
23. Malmsten M. Ellipsometry studies of protein layers adsorbed at hydrophobic surfaces. J. Colloid Interf. Sci. 1994, 166:333-342.
24. Ringstad L., Schmidtchen A., Malmsten M. Effect of peptide length on the interaction between consensus peptides and DOPC/DOPA bilayers. Langmuir 2006, 22:5042-5050.
25. Sanz-Moral L.M., Rueda M., Nieto A., Novak Z., Knez Z., Martin A. Gradual hydrophobic surface functionalization of dry silica aerogels by reaction with silane precursors dissolved in supercritical carbon dioxide. J. Supercrit. Fluids 2013, 84:74-79.
26. Burns N.L., Holmberg K., Brink C. Influence of surface charge on protein adsorption at an amphoteric surface. Effects of varying acid to base ratio. J. Colloid Interf. Sci. 1996, 178:116-122.
27. Botequim D., Maia J., Lino M.M.F., Lopes L.M.F., Simones P.N., Ilharco L.M., Ferreira L. Nanoparticles and surfaces presenting antifungal, antibacterial, and antiviral properties. Langmuir 2012, 28:7646-7656.
28. Li L.L., Wang H. Enzyme-coated mesoporous nanoparticles as efficient antibacterial agents in vivo. Adv. Healthcare Mater. 2013, 2:1351-1360.
29. Molina-Manso D., Manzano M., Doadrio J.C., Del Prado G., Ortiz-Perez A., Vallet-Regi M., Gomez-Barrena E., Esteban J. Usefulness of SBA-15 mesoporous ceramics as a delivery system for vancomycin, rifampicin and linezolid: a preliminary report. Int. J. Antimicrob. Agents 2012, 40:252-256.
30. Mas N., Galiana I., Mondragon L., Aznar E., Climent E., Cabedo N., Sancenon F., Muguia J.R., Martinez-Manez R., Marcos M.D., Amoros P. Enhanced efficacy and broadening of antibacterial action of drugs via the use of capped mesoporous nanoparticles. Eur. Chem. J. 2013, 19:11167-11171.
31. Izquierdo-Barba I., Vallet-Regi M., Kupferschmidt N., Terasaki O., Schmidtchen A., Malmsten M. Incorporation of antimicrobial compounds in mesoporous silica film monolith. Biomaterials 2009, 30. 7729-5736.
32. Sahay G., Alakhova D.Y., Kabanov A.V. Endocytosis of nanomedicines. J. Controlled Release 2010, 145:182-195.
33. Tabata Y., Ikada Y. Phagocytosis of microspheres by macrophages. Adv. Polym. Sci. 1990, 94:107-141.
34. Lichter J.A., Van Vliet K.J., Rubner M.F. Design of antibacterial surfaces and interfaces: polyelectrolyte multilayers as a multifunctional platform. Macromolecules 2009, 42:8573-8586.
35. Li X., Chen Y., Wang M., Ma Y., Xia W., Gu H. A mesoporous silica nanoparticle-PEI-fusogenic peptide system for siRNA delivery in cancer therapy. Biomaterials 2013, 34:1391-1401.
36. Pan L., He Q., Liu J., Chen Y., Ma M., Zhang L., Shi J. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc. 2012, 134:5722-5725.